Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy

Marina Baretti, Mark Yarchoan

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences